Literature DB >> 16200339

Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia.

H Toyoda1, T Honda, Y Katano, H Goto, J Takamatsu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16200339     DOI： 10.1007/s10096-005-0020-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study.

Authors:  A E Yeo; A Matsumoto; M Hisada; J W Shih; H J Alter; J J Goedert
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

2.  Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.

Authors:  D L Thomas; D Vlahov; H J Alter; J C Hunt; R Marshall; J Astemborski; K E Nelson
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

3.  Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan.

Authors:  H Toyoda; Y Fukuda; T Hayakawa; J Takamatsu; H Saito
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-03-01

4.  Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates.

Authors:  J P Hanley; L M Jarvis; P C Hayes; A J Lee; P Simmonds; C A Ludlam
Journal:  Thromb Haemost       Date:  1998-02       Impact factor: 5.249

5.  Effect of coinfection with GB virus C on survival among patients with HIV infection.

Authors:  J Xiang; S Wünschmann; D J Diekema; D Klinzman; K D Patrick; S L George; J T Stapleton
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

6.  Infection with GB virus C and reduced mortality among HIV-infected patients.

Authors:  H L Tillmann; H Heiken; A Knapik-Botor; S Heringlake; J Ockenga; J C Wilber; B Goergen; J Detmer; M McMorrow; M Stoll; R E Schmidt; M P Manns
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

7.  Detection of antibodies to a putative hepatitis G virus envelope protein.

Authors:  M Tacke; K Kiyosawa; K Stark; V Schlueter; B Ofenloch-Haehnle; G Hess; A M Engel
Journal:  Lancet       Date:  1997-02-01       Impact factor: 79.321

8.  Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia.

Authors:  J Takamatsu; H Toyoda; Y Fukuda; I Nakano; S Yokozaki; K Hayashi; H Saito
Journal:  Haemophilia       Date:  2001-11       Impact factor: 4.287

9.  GB virus C/hepatitis G virus isolates in Japanese haemophiliacs and their origins.

Authors:  H Toyoda; Y Fukuda; T Hayakawa; J Takamatsu; H Saito; H Okamoto
Journal:  Thromb Haemost       Date:  1998-08       Impact factor: 5.249

10.  Persistent GB virus C infection and survival in HIV-infected men.

Authors:  Carolyn F Williams; Donna Klinzman; Traci E Yamashita; Jinhua Xiang; Philip M Polgreen; Charles Rinaldo; Chenglong Liu; John Phair; Joseph B Margolick; Dietmar Zdunek; Georg Hess; Jack T Stapleton
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.